
- Oncology NEWS International Vol 15 No 10
- Volume 15
- Issue 10
First Three Cancers Chosen for Cancer Genome Atlas Pilot
Brain, lung, and ovarian cancers have been chosen as the first cancers to be studied in the pilot phase of The Cancer Genome Atlas (TCGA) project
WASHINGTONBrain, lung, and ovarian cancers have been chosen as the first cancers to be studied in the pilot phase of The Cancer Genome Atlas (TCGA) project, according to the National Cancer Institute (NCI) and National Human Genome Research Institute (NHGRI). These cancers, which collectively account for more than 210,000 US cancer cases each year, were selected because of the availability of biospecimen collections that met TCGA's requirements. TCGA was launched in December 2005 as a collaborative 3-year pilot project to test the feasibility of using large-scale genome analysis technologies to determine all of the important genomic changes involved in cancer.
The lung cancer biospecimens will come from CALGB's Lung Cancer Tissue Bank at Brigham and Women's Hospital, Boston. The source of the brain tumor (glioblastoma) specimens will be M.D. Anderson Cancer Center. The ovarian cancer biospecimens will be provided by the Gynecologic Oncology Group tissue bank at the Children's Hospital of Ohio State University, Columbus.
Articles in this issue
about 19 years ago
Recombinant MAGE-A3 Cancer Immunotherapy Promisingabout 19 years ago
WHI Calcium/Vit D Trial:about 19 years ago
Negative Lymph Nodes Predict Survival in Stage III Colon Caabout 19 years ago
Oophorectomy Value Varies by BRCA Typeabout 19 years ago
FDA Approves Vectibix for Metastatic Colon Caabout 19 years ago
Brain Cancer Cells Attract Stem Cells for Angiogenesisabout 19 years ago
NCCN Presents Hematologic Ca Congressabout 19 years ago
Interim Results for MediGene's Oncolytic Virus NV1020about 19 years ago
GSK Files NDA for Tykerb for Advanced Breast Cancer RxNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.